Home/Pipeline/Genialis krasID

Genialis krasID

KRAS-driven cancers

Biomarker DevelopmentActive

Key Facts

Indication

KRAS-driven cancers

Phase

Biomarker Development

Status

Active

Company

Genialis

About Genialis

Genialis is a Boston-based precision oncology company founded in 2015, focusing on using AI to de-risk and accelerate oncology drug development. Its core technology is the Genialis Supermodel, a foundation AI model of cancer biology, supported by a multiomics data infrastructure called Genialis Expressions. The company provides therapeutic intelligence across the drug development lifecycle, aiming to improve patient stratification, understand drug mechanisms of action, and increase clinical trial success rates for its biopharma partners.

View full company profile

Therapeutic Areas

Oncology

Other KRAS-driven cancers Drugs

Drug	Company	Phase	Status
ALTA-3263	Alterome Therapeutics	Phase 1	Active